explore -WSS

explore

author：entertainment 2025-10-01 07:40:57 - browse：275

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： DeSantis can now import cheaper drugs. But will Biden get credit?

focus

entertainment

hotspot

WSS

Baltimore teen accused of firing into crowd during block party mass shooting

Three issues to watch in global health in 2024

As JPM 2024 winds down, some health tech firms project optimism

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New menopause drug shows promise in relief for hot flashes

hotspot

explore

focus

Peter Hotez and the public health issue of online harassment

How I ended up pumping milk in a bathroom stall at JPM 2024

Guidelines to prevent youth baseball injuries need more muscle

Eye stem cell transplant could help restore vision in injured people

Apple is now the first public company to be valued at $3 trillion

Evacuations in place as 3 wildfires burn in eastern Washington state

Psychedelics group wrestles with new pharma identity

Doulas covered by Medicaid under New York's new plan

BioMarin wins approval for gene therapy to treat hemophilia A

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

knowledge

Caregivers of transplant patients call for more support, training

Lung cancer is America's deadliest cancer. Yet so few get screened

Majority of Americans think Trump's Ga. election interference case is serious: POLL

As Maui death toll rises, number of missing remains unclear

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

focus

entertainment

hotspot

leisure time